|
Volume 272, Number 5,
Issue of January 31, 1997
pp. 3042-3048
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Characterization of a Secretory Type Theileria parva
Glutaredoxin Homologue Identified by Novel Screening Procedure*
(Received for publication, June 10, 1996, and in revised form, September 17, 1996)
Thomas
Ebel
,
James F. S.
Middleton
§,
Angelika
Frisch
¶ and
Joachim
Lipp
¶
From the Vienna International Research Cooperation Center,
Institute of Immunology and the ¶ Department of
Vascular Biology and Thrombosis Research, University of Vienna, A-1235
Vienna, Austria and § Sandoz Forschungsinstitut
Vienna, A-1235 Vienna, Austria
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES
ABSTRACT
The schizont stage of the protozoan parasite
Theileria parva induces features characteristic of tumor
cells in infected bovine T-cell lines. Most strikingly T. parva-infected cell lines acquire unlimited growth potential
in vitro. Their proliferative state is entirely dependent
on the presence of a viable parasite within the host cell cytoplasm. It
has been postulated that parasite proteins either secreted into the
host cell or expressed on the parasite surface membrane are involved in
the parasite-host cell interaction. We used an in vitro
transcription-translation-membrane translocation system to identify
T. parva-derived cDNA clones encoding secretory or
membrane proteins. Within 600 clones we found one encoding a 17-kDa
protein which is processed by microsomal membranes to a 14-kDa protein
(11E), presumably by signal peptidase. The processed form is expressed
in the T-cell line TpM803 harboring viable parasites. By
immunolocalization we show that the 11E protein mostly resides within
the parasite, often in close vicinity to membranous structures, but in
addition it appears at the surface membrane. Amino acid sequence
comparison suggests that 11E belongs to the glutaredoxin family, but is
unique so far in containing a signal sequence for endoplasmic reticulum
membrane translocation.
INTRODUCTION
Theileria parva is an obligate intracellular protozoan
parasite that infects cattle and causes a usually fatal disease called East Coast Fever. The major pathogenic stage of the life cycle, the
schizont, is found in the cytoplasm of infected bovine lymphocytes and
replicates synchronously with the infected host cell. Infected lymphocytes undergo blast transformation and multiplication, resulting in a massive lympho-proliferation followed by lymphocytolysis and death
of the host (for review, see Ref. 1). Schizont-containing cell lines
can be maintained in vitro as permanently transformed lymphoblastoid cells exhibiting unlimited growth potential (reviewed in
Ref. 2). Proliferation of T. parva-infected cell lines is accompanied by the presence of high levels of activated NF- B in the
nucleus (3), the constitutive expression of high affinity IL-21 receptors and the secretion of IL-2.
After killing the parasite by antitheilericidal drug BW720c levels of
activated NF- B decrease rapidly, expression of high affinity IL-2
receptor and IL-2 ceases, and the lymphocytes stop to proliferate.
This reversibility of the system implies that parasite factors, most
likely proteins, induce and maintain host cell transformation. Parasite
proteins, which directly interact with the host cell, have to be
exported into the host or expressed on the parasite surface membrane.
In eucaryotes most secretory and surface proteins use a common
intracellular transport pathway. This pathway is entered by
translocation of the nascent polypeptide across the ER membrane (4, 5).
This entry step can be reconstituted in heterologous cell free
translation systems (6, 7). For proteins of different protozoan
parasites it has been shown that they can be translocated across
microsomal membranes and processed by a signal peptidase (8-10).
We have employed an in vitro
transcription-translation-translocation assay to identify secretory and
membrane proteins of the T. parva schizont. 600 individual
T. parva cDNA clones were expressed in the cell-free
system and screened for translation products, which were translocated
across microsomal membranes. One cDNA clone (plasmid 11E) was
identified encoding a secretory type protein, which is synthesized as a
17-kDa precursor protein and becomes processed by microsomal membranes
to the 14-kDa mature form (11E). Based on the amino acid sequence we
predict a signal sequence of 24 amino acids (11). In a T. parva-infected bovine T-cell line (TpM803) only the 14-kDa form is
expressed. By immunofluorescence staining we found 11E protein located
within the parasite. Higher resolution analysis by immuno-electron
microscopy suggests that 11E is predominantly associated with
intraparasitic membrane structures and the surface membrane.
11E shows significant homology on the amino acid level to glutaredoxins
including conservation of the active center motif. Glutaredoxins belong
to a superfamily of thiol active oxidoreductases and have been defined
by their ability to reduce glutathione mixed disulfides, which
distinguishes them from the related thioredoxin family (reviewed in
Ref. 12). Glutaredoxins are ubiquitously found in diverse organisms as
Escherichia coli (13-15), yeast (16), plants (17), mammals
(18-21), and even encoded by viruses (22-24). Glutaredoxins act
in vivo as cofactor for ribonucleotide reductase (12, 14).
Further physiological functions of glutaredoxins are assumed but less
established, like cofactor function for other enzymes (25, 26),
regeneration of cytoplasmic ascorbic acid (26), and restoration of
oxidatively damaged proteins (27, 28).
Compared with the described glutaredoxin sequences T. parva
11E has a cleavable signal peptide for entering the classical secretory
pathway and an additional N-terminal extension of 26 amino acids. So
far no secreted glutaredoxin family member has been described. However,
a human thioredoxin family member was shown to be secreted and involved
in activation and transformation of virally infected lymphocytes (29,
30).
MATERIALS AND METHODS
Cell Culture
The characteristics and maintenance of the
bovine lymphocyte cell line TpM803 persistently infected with T. parva Muguga have been described previously (31). TpM803 cells
were cured of the parasite by culturing for 7 days in the presence of
the theilericidal drug BW720c (Coopers Animal Health Ltd., Beckhamsted,
United Kingdom) at a concentration of 50 ng/ml. For cultivation of
cured TpM803 for more than 8 days, 10 units/ml of recombinant human
IL-2 (Amersham Corp.) and 50 ng/ml TPA were added to the medium.
Concanavalin A-stimulated bovine lymphocytes were cultured as
described (32).
cDNA Library Construction
T. parva schizont
poly(A)+ RNA was prepared from cell line TpM803 as
described previously (32). cDNA was synthesized (Amersham synthesis
kit), ligated to EcoRI linkers and inserted into plasmid vector pGem3 (Promega).
cDNA Screening by in Vitro
Transcription-Translation-Translocation
The E. coli
strain DH5 was transformed by the T. parva-pGem3 cDNA
library. Plasmid DNA of 600 randomly picked clones was digested with
EcoRI, and the insert size was analyzed on 1% agarose gels.
Clones containing inserts larger than 0.2 kilobase pair were analyzed
further.
For in vitro transcription T. parva-pGem3
plasmids were linearized by ScaI and transcription was
carried out in a 20-µl volume containing 1 µg of linearized DNA and
5 units of T7 or SP6 RNA polymerase at 37 °C for 1 h (33).
2 µl of the transcription reaction was translated in wheat germ
lysate in the presence of L-[35S]methionine
as described (14). For membrane translocation of synthesized
polypeptides, rough microsomes derived from dog pancreas were included
in the translation (7).
To test for membrane translocation of in vitro synthesized
proteins across, or insertion into, the microsomal membrane
accessability to proteinase K (PK) was used. A 10-µl aliquot of the
translation mixture containing rough microsomes was incubated for 15 min at 25 °C with either 0.3 mg/ml of PK or 0.3 mg/ml of PK and
0.5% Nonidet P-40. Further proteolysis was stopped by addition of
phenylmethylsulfonyl fluoride to 0.1 mg/ml. Samples were analyzed
by SDS-PAGE and fluorography (34).
To remove secretory and peripheral membrane proteins, rough microsomes
were subjected to carbonate extraction with 0.1 M
Na2CO3, pH 11 (35).
Southern and Northern Blots
Genomic DNA from concanavalin
A-stimulated lymphocytes, TpM803 cells, T. parva piroplasms
was prepared according to standard procedures as was
poly(A)+ RNA from infected and drug-treated TpM803 cells
(32, 36). Genomic Southern and Northern blot analyses were performed in a standard fashion (37). Blots were washed for 30 min each in 2 × SSC, 0.1% SDS at room temperature, 1 × SSC, 0.1% SDS at
65 °C, 2 × with 0.1 × SSC at 65 °C.
DNA Sequencing and Analysis
The cDNA insert 11E was
subcloned as a HindIII-PvuII fragment into
plasmids pUC18/19 (Life Technologies, Inc.) and sequenced. Nucleotide
and amino acid sequence analysis and comparison were carried out using
the GCG program and the GenBankTM/EMBL data base (38).
Preparation of 11E Fusion Protein
A
HindII-PvuII fragment of plasmid 11E-pGem3
encoding the C-terminal portion of protein 11E, starting with residue
56 was cloned into the SmaI site of plasmid pEX3. The
bacterial -galactosidase-11E fusion protein was prepared and
gel-purified as described (39).
Antiserum Preparation
A female Chinchilla rabbit was
injected intradermally with 200 µg of the purified
-galactosidase-11E fusion protein, emulsified in complete Freund's
adjuvant, on days 1, 9, 15, 22, and 43. Preimmune serum was collected
on day 1 prior to immunization, and the immune serum used in the
experiments was prepared on day 50.
Blot Adsorption
Antiserum 27 was depleted of antibodies
toward -galactosidase by adsorption to bacterial proteins blotted
onto nitrocellulose membranes. pEX3-transformed E. coli
cells were spread on LB agar plates, grown overnight at 30 °C to
confluent layers, transferred to nitrocellulose membranes, then induced
at 42 °C for 2 h and lysed. Bacterial proteins were blotted
onto the nitrocellulose, DNase-treated, washed, and blocked for
1.5 h as for Western blots (39). Antiserum 27 was diluted 1:20 in
0.2% gelatin, phosphate-buffered saline, 0.1% Tween 20, 20 µg/ml
phenylmethylsulfonyl fluoride, 0.05% NaN3 and incubated
with the filters for 18 h at 4 °C. The solution was collected
and lack of reactivity toward -galactosidase was confirmed by
Western blotting. Next, the lysate of TpM803 cells was separated on
preparative 18% SDS-polyacrylamide gels and transferred to a
nitrocellulose membrane. The localization of the antigens specifically
recognized by antiserum 27 was determined by Western blotting with test
strips using the -galactosidase-depleted antibody fraction, the
preimmune and immune serum 27 serving as controls. The region
containing the 14-kDa antigen was excised, and the remainder of the
membrane was incubated with the -galactosidase-depleted antiserum as
above. The adsorption to TpM803 cell blots, from which the 14-kDa 11E
antigen had been removed, was repeated twice. For these experiments
cell lysates were used in which the 10-kDa antigen was not detectable.
The reactivity of the depleted serum was tested toward proteins of the
TpM803 cell lysate by Western blotting, as above. The resultant
antibody preparation reacted exclusively with the 14- and 10-kDa
antigens in Western blots (see Fig. 5). The specificity of depleted
antiserum 27 was controlled on Western blots by recognition of a
glutathione S-transferase fusion protein containing the
identical 11E C-terminal segment as in the -galactosidase fusion
protein (data not shown).
Fig. 5.
Immunoprecipitation of in vitro
and TpM803 expressed 11E protein. cDNA clone 11E was
transcribed in vitro and translated in the presence of rough
microsomes (lane 1). An aliquot of the reaction was treated
with proteinase K (PK) (lane 2). PK-treated microsomes were solubilized and used for immunoprecipitation with either preimmune serum (lane 3) or immune serum (lane
4). Detergent lysates of metabolically labeled TpM803 cells were
subjected to immunoprecipitation with either preimmune serum
(lane 5) or immune serum (lane 6). Samples were
analyzed by SDS-PAGE (18%) and fluorography. Molecular mass standards
are indicated.
[View Larger Version of this Image (52K GIF file)]
Metabolic Cell Labeling and Immunoprecipitation
TpM803
cells were sedimented, resuspended at 5 × 105
cells/ml in methionine/cysteine-free minimum essential medium
supplemented with 10 mM HEPES, pH 7.4, 2 mM
L-glutamine, 0.5% fetal calf serum, 3.75 MBq/ml each of
L-[35S]methionine and
L-[35S]cysteine and cultured for 18 h.
Cells were washed with phosphate-buffered saline and lysed on ice with
precooled buffer containing 1% Nonidet P-40, 0.1% SDS, 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 2 mM EDTA, 20 µg/ml phenylmethylsulfonyl fluoride, 1 µM leupeptin, 0.3 µM aprotinin, and 1 µM pepstatin. Debris was pelleted by a 5-min spin in a
microcentrifuge, and the resultant supernatant was clarified by
ultracentrifugation for 1 h at 4 °C, 100,000 × g. After posttranslational in vitro assays,
antigens in a 50-µl aliquot were solubilized by adding 2 volumes of
cell lysis buffer. Samples were incubated with 5 µl of preimmune or
antiserum 27 for 2 h at 4 °C. Immunocomplexes were collected on
40 µl of 50% (w/v) protein A-Sepharose slurry, washed, and prepared
for SDS-PAGE as described (34).
Western Blots
Protein lysates of bacteria and lymphocytes
were prepared, separated by SDS-PAGE, electrophoretically transferred
to nitrocellulose membranes, and probed with rabbit sera as described
(34). Detection of the primary antibody was with peroxidase-coupled
donkey anti-rabbit Ig (Amersham diluted 1:5000) and diaminobenzidene
substrate reaction (40).
Immunofluorescence
Indirect staining and Hoechst 33258 staining of formaldehyde-fixed, permeabilized TpM803 cells with
depleted antiserum 27 or preimmune serum was performed essentially as
described (34). Briefly cells were washed with phosphate-buffered
saline, centrifuged onto coverslips (Shandon cytofuge, 1000 rpm, 5 min), fixed, and incubated with depleted rabbit serum 27 diluted 1:10.
Detection was with rhodamine-conjugated donkey F(ab )2
anti-rabbit IgG (Dianova, Hamburg, diluted 1:400). For double staining
with the DNA dye Hoechst 33258, 1 µg/ml was included in the secondary
reagent solution. Photographs were taken on a Zeiss Axioskop microscope
using Fuji Neopan 1600 professional film.
Immuno-electron Microscopy
Cell suspensions were fixed for
1 h at room temperature in 4% glutaraldehyde, 0.5 mM
calcium chloride, 0.2% picric acid in 0.1 M phosphate
buffer, pH 7.4. The cells were centrifuged at 500 × g
for 5 min and processed according to (41), except that cells were
dehydrated in ethanol and embedded in Lowicryl HM 20. Ultra-thin
sections were cut and immunolabeled with depleted immune serum 27 as
described (42). Control sections were incubated in preimmune serum.
Detection was with 5-nm colloidal gold particles conjugated with goat
anti-rabbit IgG (Amersham) followed by silver enhancement (Amersham
kit).
RESULTS
Identification of cDNA Clone 11E
We were interested in
determining proteins which are directly involved in the interaction of
T. parva and its host the bovine T-lymphocyte. Since the
schizont stage of T. parva is obligate intracellular and
cannot be cultured in a free form, we developed a general method to
identify proteins which enter the secretory pathway of eucaryotic
cells. Our screening system is based on cell-free expression of
cDNA in an in vitro transcription-translation-membrane translocation system. Proteins which fulfil the criterion of being translocated across ER-derived membranes are prime candidates to be
exported or transported to the cell surface via the secretory transport
route.
Screening about 600 clones of a schizont cDNA library we identified
clone 11E, which upon cell-free expression encodes a protein product
with the characteristics of a secretory protein (Fig. 1). The 11E transcript was translated into a polypeptide
with apparent molecular mass of 17 kDa (lane 1). When
translation was carried out in the presence of rough microsomes (RM),
an additional form of 14 kDa size was observed (lane 3).
Following addition of PK, the 17-kDa form was digested, whereas the
14-kDa form was protected from protease (lane 4). After
solubilization of the microsomal membranes and PK treatment, the 14-kDa
form was digested to a 10-kDa PK-resistant fragment (lane
5). Similarly bacterial chloramphenicol acetyltransferase has been
shown to be partially resistant to PK digestion (43). We conclude that
the primary translation product of 17 kDa was translocated across the
microsomal membrane and processed to a 14-kDa form presumably by signal
peptide cleavage.
Fig. 1.
Cell-free expression of cDNA clone
11E. 11E protein was synthesized in a wheat germ cell-free
translation system in the absence (lanes 1 and 2)
or presence (lanes 3-5) of dog pancreas microsomes
(RM). Following translation, proteinase K (PK)
was added to an aliquot of the reaction mixtures, either in the absence (lane 4) or in the presence (lanes 2 and
5) of nonionic detergent Nonidet P-40 (NP40). An
aliquot of the reaction mixture shown in lane 3 was
subjected to carbonate extraction. The pellet (P) and
supernatant (S) were processed separately. Samples were
reduced and separated by SDS-PAGE (15%). Molecular mass standards are indicated.
[View Larger Version of this Image (52K GIF file)]
11E transcript was translated in the presence of RM and membrane
integration of the 14-kDa form was tested by carbonate extraction of
salt-washed microsomes at pH 11 (35). The pellet fraction (P) and the supernatant fraction (S) were
analyzed by SDS-PAGE (Fig. 1). The 14-kDa form was exclusively found in
the S fraction, which indicates that this form is not integrated into
the membrane and behaves like secretory type proteins. The 17-kDa form
is found in both fractions. Its presence in the supernatant can be
explained by polypeptide chains not translocated but loosely associated with the microsomes. Its presence in the pellet fraction is due to
inefficient processing by signal peptidase as has been observed for
other proteins (44).
cDNA Clone 11E Is Derived from the T. parva Genome and
Expressed in T. parva-infected Lymphocytes
After having
identified the cDNA clone 11E we wanted to show that it is T. parva-specific and not derived from the host cell. We performed
Southern blot analysis with genomic DNA from concanavalin A-stimulated
lymphocytes, a T. parva-infected T-cell line (TpM803), and
T. parva piroplasms. As shown in Fig. 2, a
single specific band was detected for TpM803 cells and piroplasms upon
hybridization with the 11E cDNA probe. No signal was obtained with
DNA from concanavalin A-stimulated bovine lymph node cells. DNA from
isolated T. parva piroplasms was used to confirm that 11E
gene was of parasite origin. Integrity of bovine genomic DNAs used in
this experiment was controlled by hybridization with bovine actin
cDNA (data not shown).
Fig. 2.
cDNA clone 11E is derived from T. parva. 12.5 µg of genomic DNA from ConA-stimulated bovine
lymphocytes (ConA), T. parva-infected TpM803
cells (TpM) and T. parva piroplasms
(Ppl) was digested with HindIII (H) or
PstI (P). Southern analysis was performed using
radiolabeled 11E cDNA as a hybridization probe.
[View Larger Version of this Image (62K GIF file)]
To show expression of the 11E gene we performed Northern analysis using
11E cDNA as hybridization probe (Fig. 3).
Noninfected concanavalin A-stimulated bovine lymph node cells (ConA)
were negative. A single transcript of 0.6 kilobase pair was detected in
TpM803 cells (TpM). In TpM803 cells that had been cured from the parasite by treatment with the theilericidal drug BW720c (cured) as
well as in cured TpM803 cells stimulated to proliferate with recombinant IL-2 and TPA (cured + IL2/TPA), no signal was
obtained. Rehybridization of the stripped filter with bovine actin
cDNA as a probe resulted in specific signals for all samples (data not shown). These results demonstrate that the 11E cDNA clone is of
parasite origin and that the 11E gene is expressed in the schizont.
Fig. 3.
The 11E gene yields a single transcript in
TpM803 cells. 2.5 µg of poly(A)+ RNA from
ConA-stimulated bovine lymphocytes (ConA), T. parva-infected TpM803 cells (TpM), and BW720c-treated
TpM803 cells (cured), cultured either with or without IL-2
and TPA, was transfered onto nylon membrane (GeneScreen Plus, DuPont)
and hybridized with radiolabeled 11E cDNA. The mobility of RNA size
standards is indicated.
[View Larger Version of this Image (28K GIF file)]
11E Is a Secretory Type Protein with Homology to
Glutaredoxin
The 11E cDNA has a length of 574 nucleotides,
including a poly(A) tail of 49 nucleotides. The in vitro
translation product of 17 kDa can be assigned to an open reading frame
encoding a polypeptide of 151 residues starting at nucleotide 14. Other
open reading frames starting with an ATG codon are too short to encode a 17-kDa polypeptide. The deduced primary amino acid sequence, shown in
Fig. 4, contains an amino-terminal signal peptide for ER
translocation with a predicted cleavage site at cysteine 24 (11). The
calculated molecular masses of the primary product of 17,528 and 14,853 Da of the processed form agree well with the apparent molecular masses
of the cell-free translation products (see Fig. 1). Furthermore, when
the cDNA is expressed in E. coli, two forms
corresponding to the precursor product and the processed product are
observed (data not shown).
Fig. 4.
Amino acid sequence of cDNA clone
11E. The primary sequence of the 151-residue polypeptide 11E
encoded by the open reading frame from nucleotides 14 to 466 is aligned
to the sequence of glutaredoxin from calf thymus (bovGlrx;
Ref. 18). Vertical bars indicate amino acid identity, and
colons indicate conservative amino acid changes. To obtain
maximal alignment, a gap marked by dashes was introduced.
The signal peptide is indicated by a broken double
underline, and the active center motif of glutaredoxins is
overlined. A glutaredoxin consensus sequence is shown in
capital letters below (consensus; Ref. 44).
[View Larger Version of this Image (27K GIF file)]
The sequence of the processed 11E polypeptide can be divided into two
parts. First, the carboxyl-terminal segment spanning residues 51-151
shows significant homology to glutaredoxins, a family of thiol-active
oxidoreductases (reviewed in Ref. 12). The highest homology was found
to glutaredoxin from calf thymus (bovGlrx) (18). There was
37% identity over amino acids 51-151 of 11E. Nikkola and co-workers
(44) have identified 29 highly conserved residues of glutaredoxins
by sequence comparison. In the 11E sequence 15 of those are identical
and 8 can be regarded as conservative changes (Fig. 4). Importantly,
the active center motif Cys-Pro-Tyr-Cys is conserved in 11E. The two
cysteines, assumed to form an intramolecular disulfide bridge in
several mammalian family members, are absent in the 11E sequence like in the yeast glutaredoxin (16). Second, the amino-terminal region of
processed 11E (residues 25-50) has no homology to described sequences
and does not contain known sequence motifs.
Intracellular Processing and Expression of the 11E Protein in
TpM803 Cells
In the cell-free expression system the 11E protein
is processed by a signal peptidase to a 14-kDa form. If the same
processing occurs in vivo the cellular protein and the
cell-free expressed RM-processed form of 11E would have identical
molecular weights. However, further modifications of 11E might occur
in vivo. To test for signal peptide cleavage of the 11E
protein in the schizont, its electrophoretic mobility in SDS-PAGE was
compared with its in vitro synthesized, processed form (Fig.
5). 11E was translated in vitro both in the
absence (not shown) and in the presence of RM. In the presence of
microsomes the 17-kDa precursor was partially processed to the 14-kDa
form (lane 1). An aliquot of the translation assay with RM,
shown in lane 1, was treated with PK. The 17-kDa precursor
form was digested, whereas the 14-kDa form was protected by microsomes
(lane 2). To an aliquot of the translation assay with RM,
which had been posttranslationally treated with PK (lane 2),
detergent buffer was added to solubilize the microsomes. The detergent
lysate was split and used for immunoprecipitation. The 14-kDa form
could be specifically immunoprecipitated with antiserum 27, but not
with the preimmune serum (lanes 3 and 4).
Likewise, 11E antigen was immunoprecipitated with antiserum 27 from
detergent lysates of metabolically labeled TpM803 cells (lane
6). The in vitro synthesized RM-processed 14-kDa form
and the 11E antigen from schizont-infected cells had identical
electrophoretic mobility (compare lanes 4 and 6).
These results demonstrate that the 11E protein is proteolytically
processed, most likely by a signal peptidase.
To corroborate the specificity of antiserum 27 we performed immunoblots
using lysates of infected and cured TpM803 cells (Fig. 6). Three antigens with apparent molecular masses of 28, 14, and 10 kDa were specifically recognized by the immune serum (strip 2). The 14-kDa antigen corresponds well to the processed form synthesized in vitro and the antigen found in infected
cells. The 10-kDa antigen is likely to be a degradation product rather than that generated by specific proteolytic processing, because it was
observed in some experiments only. To determine whether the 28-kDa
antigen represents a modified form of the 11E gene product, we depleted
antiserum 27 of binding activities to antigens other than the 14-kDa
antigen by sequential immunoadsorption (see "Materials and
Methods"). The depleted antiserum fraction no longer recognized the
28-kDa antigen, but still reacted with the 14- and the 10-kDa antigens
(strip 3), further supporting the assumption that the 10-kDa form is
derived from the 14-kDa form. The loss of binding to the 28-kDa antigen
indicates that it is not an unreduced 14-kDa homodimer and that
recognition is due to cross-reactivity to another T. parva
protein. Samples cured of the parasite showed that the expression of
28-, 14-, and 10-kDa antigens is specific for TpM803 cells (strips 4 and 5).
Fig. 6.
Cured TpM803 cells do not express 11E
protein. Lysates of 106 cells/lane were
electrophoretically separated on an 18% SDS-polyacrylamide gel and
transferred to a nitrocellulose membrane. After staining with Ponceau S
(Sigma), the lanes were cut off and probed with antisera as follows: TpM803 cells (lane 1) and
BW720c-treated TpM803 cells (lane 4) with preimmune serum,
diluted 1:200; TpM803 cells (lane 2) and BW720c-treated
TpM803 cells (lane 5) with immune serum 27, diluted 1:200;
and TpM803 cells (lane 3) with depleted immune serum 27. Detection of bound antibody was with horseradish peroxidase-conjugated
secondary antibody and diaminobenzidene reaction. The arrow
marks the mobility of the specifically recognized 14-kDa 11E antigen.
Molecular mass standards are indicated.
[View Larger Version of this Image (34K GIF file)]
Subcellular Localization of the 11E Protein
To localize the
secretory type protein 11E within the parasite-host cell system, we
performed indirect immunofluorescence staining on formaldehyde-fixed,
permeabilized TpM803 cells. As the primary antibody a 14-kDa
antigen-specific preparation of antiserum 27 was used (compare with
Western analysis, Fig. 6). This preparation reacted specifically with
distinct subcellular regions of TpM803 cells (Fig.
7A). Double labeling with the DNA binding dye
Hoechst 33258 revealed that the immunolabeled clusters always lay in
the region of infected cells where the nuclei of the multinucleate
schizonts localized (Fig. 7C). When cured TpM803 cells were
analyzed we observed no region-specific immunostaining (Fig.
7B). Double labeling with Hoechst 33258 was used to confirm the loss of the parasite (Fig. 7D). Preimmune serum was used
as a control and resulted in nonspecific background staining in
infected and cured cells (data not shown).
Fig. 7.
The 11E antigen is localized in the
schizont. Formaldehyde-fixed, detergent permeabilized, TpM 803 (A) or cured TpM803 cells treated with BW720c (B)
were labeled by indirect fluourescence staining using depleted immune
serum 27. C and D show double labeling of
specimen A and B, respectively, with Hoechst dye
33258. Specimen were photographed using an automatic device (Wild MPS
45). Exposure times: 20 s (A), 90 s
(B), 5 s (C), and 10 s
(D).
[View Larger Version of this Image (140K GIF file)]
It was not possible to deduce a clear subcellular localization from the
immunofluorescence data. Therefore we analyzed the 11E antigen
distribution by immuno-electron microscopy. Ultra-thin sections of
TpM803 cells were fixed with glutaraldehyde/picric acid, embedded in
Lowicryl HM 20, and labeled with depleted antiserum 27. Detection was
with 5-nm gold particle-labeled secondary antibody and silver
enhancement. Fig. 8A shows an overview of an
infected cell in which the boundary of the schizont (S) can
be clearly seen. Fig. 8B is taken from the same specimen and
shows part of the schizont (upper right in A) at
higher magnification. Specific labeling was observed only within the
schizont, frequently at membranous structures, including the parasite
surface. These membranous structures could not be ascribed to defined
subcellular compartments, because the schizont lacks clear
ultrastructural organization recognizable by electron microscopy
(45).
Fig. 8.
Subcellular distribution of 11E antigen.
TpM803 cells were fixed with glutaraldehyde/picric acid and embedded in
Lowicryl HM 20. Ultra-thin sections were immunolabeled with depleted
immune serum 27. Detection was with 5-nm colloidal gold-goat
anti-rabbit IgG and silver enhancement. A shows a TpM803
cell; the host cell nucleus (N) and the schizont
(S) are marked. B shows part of the schizont from
the same specimen in higher magnification. Gold particularly localizes
to membrane structures within the parasite and at the parasite cell
surface (arrowheads). The scale bars represent
0.5 (A) or 0.1 (B) µm, respectively.
[View Larger Version of this Image (151K GIF file)]
Taken together these data show that the 11E protein is localized in the
schizont and is partially associated with intracellular and surface
membranes.
DISCUSSION
Since the intracellular schizont stage of T. parva
induces and maintains the proliferative phenotype of infected
lymphocytes, and since it can only be prepared in a form suitable for
mRNA isolation but not for analysis of exported proteins, we
developed a novel approach to identify secretory and surface proteins.
The screening strategy is based on the fact that the entry step of eucaryotic proteins into the secretory transport route, namely the
translocation across the membrane of the ER, can be reconstituted and
assayed in heterologous, cell-free, coupled translation-translocation systems. This procedure is not limited to our experimental system and
may also be useful to identify secretory and surface proteins of other
obligate intracellular pathogens or other systems where cells of
interest cannot be propagated. Inherent in the technique is the
selectivity for full-length cDNA clones since, except for some
classes of transmembrane proteins, the signal sequence for ER
translocation is in nearly all cases at the extreme amino terminus. However, there is the possibility that incomplete cDNA clones start
with an internal transmembrane region that can mimic a functional signal sequence (46). There is a potential for false positives due to
incomplete cDNA clones carrying cryptic signal sequences (47). This
implies that for any protein identified by this screening procedure,
its subcellular localization remains to be determined. So far we have
analyzed 600 cDNA clones and obtained two candidates, which
unequivocally fulfil the criterion of being translocated across
microsomal membranes.
We have shown here that the 11E signal sequence is functional and
cleaved off in a heterologous cell free system. Second, we have also
demonstrated that the schizont expresses a processed 11E protein, which
together with the subcellular localization data led us to conclude that
the signal sequence operates as topogenic signal in the schizont.
This study on the 11E protein provides direct evidence for the first
time that in T. parva the classical secretory pathway is
operating, as has been shown for other intracellular protozoans (Trypanosoma brucei (8); Plasmodium lophurae (9);
Plasmodium falciparum (10); for review, Toxoplasma
gondii (48) and references therein). Our biochemical evidence for
a functional ER is important, since with microscopical techniques an
ER-like structure is not detectable in the schizont stage, except when
it differentiates at the beginning of merogony (45).
To date the reported glutaredoxin family members lack intracellular
transport signals and reside in the cytoplasm. 11E is the first
glutaredoxin-like protein described to enter the secretory transport
pathway. Interestingly, the T. parva homologue of the catalytic subunit of casein kinase II appears to represent a similar case. In cells of other organisms the enzyme is usually found in the
cytoplasm and nucleus. The cloned T. parva casein kinase II
homologue is also preceeded by a consensus signal peptide for ER
translocation and an intervening sequence without homology to described
proteins (49). It appears to be an attractive hypothesis that the
schizont uses its secretory pathway to position parasite proteins in
the host cell, which then can modulate the host cell physiology.
Various, partially overlapping, cellular functions have been ascribed
to glutaredoxins and other members of the oxidoreductase superfamily
they belong to (12, 25-28). It has to be shown whether the 11E protein
has any of the described glutaredoxin or other oxidoreductase
activities.
Other members belonging to the thiol active oxidoreductase superfamily
exist, which are exported. In Gram-negative bacteria, some family
members are either integral membrane proteins or bound to the
periplasmic face of the inner membrane as part of an oligomeric protein
complex (for review, see Ref. 50). Based on the localization of 11E
protein, in close vicinity to membranous structures, it is conceivable
that 11E protein participates in a membrane protein complex of the
schizont. One would expect 11E to be exposed at the extracellular side
of the schizont plasma membrane exerting its enzymatic activity toward
the host cell cytoplasm.
Adult T-cell leukaemia-derived factor is a protein with more than 90%
homology to human thioredoxin. It shows oxidoreductase activity and is
secreted by a yet unknown mechanism. It has been shown to induce IL-2
receptor/tac antigen expression and to be involved in lymphocyte
immortalization by human T-cell lymphotrophic virus, type I and
Epstein-Barr virus (29, 30, 51). Increased tac antigen expression is
essential for continuous proliferation of T. parva-infected
bovine lymphocytes (52). It is tempting to speculate that 11E might
play a crucial role in the induction of IL-2 receptor expression in
TpM803 cells.
FOOTNOTES
*
This work was supported by Grants Li 491/1-1 from the
Deutsche Forschungsgemeinschaft and special project funding
89.7860.3-01-100 from the Deutsche Gesellschaft für Technische
Zusammenarbeit. The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) U48417[GenBank] (clone 11E).
To whom all correspondence should be addressed: VIRCC, Dept.
of Vascular Biology and Thrombosis Research, Brunnerstr. 59, A-1235
Vienna, Austria. Tel.: 43-1-86634-565; Fax: 43-1-86634-623.
1
The abbreviations used are: IL-2, interleukin-2;
ER, endoplasmic reticulum; PK, proteinase K; RM, rough microsomes; TPA, phorbol 12-myristate 13 acetate; ConA, concanavalin A; PAGE,
polyacrylamide gel electrophoresis.
Acknowledgments
We are grateful to Coopers Animal Health
Ltd., UK, for providing us with BW720c. We thank Dr R. deMartin for
critical reading of the manuscript and helpful comments. For
immunization of rabbits and serum collection, we thank M. Zsak.
REFERENCES
-
Williams, R. O., and Dobbelaere, D. A. E.
(1993)
Semin. Cell Biol.
4,
363-371
[CrossRef][Medline]
[Order article via Infotrieve]
-
Morrison, W. E., Lalor, P. A., Goddeeris, B. M., and Teale, A. J.
(1986)
in
Parasite Antigens (Pearson, T. W., ed), pp. 167-213, Marcel Dekker Inc., New York
-
Ivanov, V., Stein, B., Baumann, I., Dobbelaere, D. A., Herrlich, P., and Williams, R. O.
(1989)
Mol. Cell. Biol.
9,
4677-4686
[Abstract/Free Full Text]
-
Palade, G.
(1975)
Science
189,
347-358
[Free Full Text]
-
Burgess, T. L., and Kelly, R. B.
(1987)
Annu. Rev. Cell Biol.
3,
243-293
[CrossRef]
-
Blobel, G., and Dobberstein, B.
(1975)
J. Cell Biol.
67,
852-862
[Abstract/Free Full Text]
-
Blobel, G., and Dobberstein, B.
(1975)
J. Cell Biol.
67,
835-851
[Abstract/Free Full Text]
-
McConnell, J., Cordingley, J. S., and Turner, M. J.
(1982)
Mol. Biochem. Parasitol.
6,
161-174
[CrossRef][Medline]
[Order article via Infotrieve]
-
Feder, R., and Blobel, G.
(1983)
Mol. Biochem. Parasitol.
9,
351-362
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lingelbach, K. R.
(1993)
Exp. Parasitol.
76,
318-327
[CrossRef][Medline]
[Order article via Infotrieve]
-
von Heijne, G.
(1983)
Eur. J. Biochem.
133,
17-21
[Medline]
[Order article via Infotrieve]
-
Holmgren, A.
(1989)
J. Biol. Chem.
264,
13963-13966
[Free Full Text]
-
Holmgren, A.
(1979)
J. Biol. Chem.
254,
3664-3671
[Free Full Text]
-
Åslund, F., Ehn, B., Miranda, V. A., Pueyo, C., and Holmgren, A.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
9813-9817
[Abstract/Free Full Text]
-
Åslund, F., Nordstrand, K., Berndt, K. D., Nikkola, M., Bergman, T., Ponstingl, H., Jörnvall, H., Otting, G., and Holmgren, A.
(1996)
J. Biol. Chem.
271,
6736-6745
[Abstract/Free Full Text]
-
Gan, Z.-R., Polokoff, M. A., Jacobs, J. W., and Sardana, M. K.
(1990)
Biochem. Biophys. Res. Comm.
168,
944-951
[CrossRef][Medline]
[Order article via Infotrieve]
-
Minakuchi, K., Yabushita, T., Masumura, T., Ichihara, K., and Tanaka, K.
(1994)
FEBS Lett.
337,
157-160
[CrossRef][Medline]
[Order article via Infotrieve]
-
Klintrot, I.-M., Höög, J.-A., Jörnvall, H., Holmgren, A., and Luthman, M.
(1984)
Eur. J. Biochem.
144,
417-423
[Medline]
[Order article via Infotrieve]
-
Gan, Z.-R., and Wells, W. W.
(1987)
J. Biol. Chem.
262,
6699-6703
[Abstract/Free Full Text]
-
Hopper, S., Johnson, R. S., Vath, J. E., and Biemann, K.
(1989)
J. Biol. Chem.
264,
20438-20447
[Abstract/Free Full Text]
-
Padilla, C. A., Martinez, G. E., Barcena, J. A., Spyrou, G., and Holmgren, A.
(1995)
Eur. J. Biochem.
227,
27-34
[Medline]
[Order article via Infotrieve]
-
Sjöberg, B. M., and Holmgren, A.
(1972)
J. Biol. Chem.
247,
8063-8068
[Abstract/Free Full Text]
-
Ahn, B. Y., and Moss, B.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
7060-7064
[Abstract/Free Full Text]
-
Gvakharia, B. O., Hanson, E., Koonin, E. K., and Mathews, C. K.
(1996)
J. Biol. Chem.
271,
15307-15310
[Abstract/Free Full Text]
-
Goswami, A., and Rosenberg, I. N.
(1985)
J. Biol. Chem.
260,
6012-6019
[Abstract/Free Full Text]
-
Wells, W. W., Xu, D. P., Yang, Y., and Rocque, P. A.
(1990)
J. Biol. Chem.
265,
15361-15364
[Abstract/Free Full Text]
-
Axelsson, K., and Mannervik, B.
(1983)
FEBS Lett.
152,
114-118
[CrossRef][Medline]
[Order article via Infotrieve]
-
Terada, T., Oshida, T., Nishimura, M., Maeda, H., Hara, T., Hosomi, S., Mizoguchi, T., and Nishihara, T.
(1992)
J. Biochem. (Tokyo)
111,
688-692
[Abstract/Free Full Text]
-
Tagaya, Y., Maeda, Y., Mitsui, A., Kondo, N., Matsui, H., Hamuro, J., Brown, N., Arai, K.-i., Yokata, T., Wakasugi, H., and Yodoi, J.
(1989)
EMBO J.
8,
757-767
[Medline]
[Order article via Infotrieve]
-
Wakasugi, N., Tagaya, Y., Wakasugi, H., Mitsui, A., Maeda, M., Yodoi, J., and Tursz, T.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
8282-8286
[Abstract/Free Full Text]
-
Emery, D. L., Morrison, W. I., Nelson, R. T., and Murray, M.
(1981)
in
Advances in the Control of Theileriosis (Irvin, A. D., Cunningham, M. P., and Young, A. S., eds), pp. 295-310, Martinus Nijhoff, Den Haag, Netherlands
-
Gerhards, J., Gill, A. C., Ehrfeld, A. Y. B., Dobbelaere, D. A. E., and Williams, R. O.
(1989)
Mol. Biochem. Parasitol.
34,
15-24
[CrossRef][Medline]
[Order article via Infotrieve]
-
Ragge, K., Arnold, H. H., Tummler, M., Knapp, B., Hundt, E., and Lingelbach, K.
(1990)
Mol. Biochem. Parasitol.
42,
93-100
[CrossRef][Medline]
[Order article via Infotrieve]
-
Gerhards, J., Ebel, T., Dobbelaere, D. D., Morzaria, S. P., Musoke, A. J., Williams, R. O., and Lipp, J.
(1994)
Mol. Biochem. Parasitol.
68,
235-246
[CrossRef][Medline]
[Order article via Infotrieve]
-
Fujiki, Y., Hubbard, A. L., Fowler, S., and Lazarow, P. B.
(1982)
J. Cell. Biol.
93,
97-102
[Abstract/Free Full Text]
-
Allsopp, B. A., and Allsopp, M. T.
(1988)
Mol. Biochem. Parasitol.
28,
77-83
[CrossRef][Medline]
[Order article via Infotrieve]
-
Sambrook, J., Fritsch, E. F., and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
-
Devereux, J., Haeberli, P., and Smithies, O.
(1984)
Nucleic Acids Res.
12,
387-395
-
Stanley, K. K., and Luzio, J. P.
(1984)
EMBO J.
3,
1429-1434
[Medline]
[Order article via Infotrieve]
-
Towbin, H., Staehelin, T., and Gordon, J.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
4350-4354
[Abstract/Free Full Text]
-
Berryman, M. A., and Rodewald, R. D.
(1990)
J. Histochem. Cytochem.
38,
159-170
[Abstract]
-
Robertson, D., Monaghan, P., Clarke, C., and Atherton, A. J.
(1992)
J. Microsc. (Paris)
168,
85-100
-
Lipp, J., and Dobberstein, B.
(1986)
Cell
46,
1103-1112
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lipp, J., and Dobberstein, B.
(1988)
J. Cell Biol.
106,
1813-1820
[Abstract/Free Full Text]
-
Shaw, M. K., and Tilney, L. G.
(1992)
J. Cell Sci.
101,
109-123
[Abstract/Free Full Text]
-
Zerial, M., Huylebroeck, D., and Garoff, H.
(1986)
Cell
48,
147-155
-
Kaiser, C. A., Preuss, D., Grisafi, P., and Botstein, D.
(1987)
Science
235,
312-317
[Abstract/Free Full Text]
-
Sibley, L. D.
(1993)
Semin. Cell Biol.
4,
335-344
[CrossRef][Medline]
[Order article via Infotrieve]
-
ole-MoiYoi, M. O., Sugimoto, C., Conrad, P. A., and Macklin, M. D.
(1992)
Biochemistry
31,
6193-6202
[CrossRef][Medline]
[Order article via Infotrieve]
-
Loferer, H., and Hennecke, H.
(1994)
Trends Biochem. Sci.
19,
169-171
[CrossRef][Medline]
[Order article via Infotrieve]
-
Yodoi, J., and Tursz, T.
(1991)
Adv. Cancer Res.
57,
381-411
[Medline]
[Order article via Infotrieve]
-
Dobbelaere, D. A., Coquerelle, T. M., Roditi, I. J., Eichhorn, M., and Williams, R. O.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
4730-4734
[Abstract/Free Full Text]
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. S. Ahmed, E. J. Glass, D. A. Salih, and U. Seitzer
Review: Innate immunity to tropical theileriosis
Innate Immunity,
February 1, 2008;
14(1):
5 - 12.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Daubenberger, D. Diaz, M. Curcic, M. S. Mueller, T. Spielmann, U. Certa, J. Lipp, and G. Pluschke
Identification and Characterization of a Conserved, Stage-Specific Gene Product of Plasmodium falciparum Recognized by Parasite Growth Inhibitory Antibodies
Infect. Immun.,
April 1, 2003;
71(4):
2173 - 2181.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|